NVCT vs. MRNA
Compare and contrast key facts about Nuvectis Pharma Inc (NVCT) and Moderna, Inc. (MRNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVCT or MRNA.
Correlation
The correlation between NVCT and MRNA is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NVCT vs. MRNA - Performance Comparison
Key characteristics
NVCT:
0.06
MRNA:
-0.94
NVCT:
0.86
MRNA:
-1.47
NVCT:
1.13
MRNA:
0.82
NVCT:
0.08
MRNA:
-0.65
NVCT:
0.16
MRNA:
-1.20
NVCT:
39.35%
MRNA:
50.95%
NVCT:
99.68%
MRNA:
65.74%
NVCT:
-77.89%
MRNA:
-93.70%
NVCT:
-61.84%
MRNA:
-93.19%
Fundamentals
NVCT:
$174.92M
MRNA:
$12.70B
NVCT:
-$1.30
MRNA:
-$9.28
NVCT:
$0.00
MRNA:
$2.26B
NVCT:
-$13.40M
MRNA:
$1.46B
NVCT:
-$13.40M
MRNA:
-$2.28B
Returns By Period
In the year-to-date period, NVCT achieves a 44.18% return, which is significantly higher than MRNA's -20.66% return.
NVCT
44.18%
45.25%
24.20%
-0.89%
N/A
N/A
MRNA
-20.66%
-5.12%
-62.01%
-63.80%
11.70%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVCT vs. MRNA — Risk-Adjusted Performance Rank
NVCT
MRNA
NVCT vs. MRNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nuvectis Pharma Inc (NVCT) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVCT vs. MRNA - Dividend Comparison
Neither NVCT nor MRNA has paid dividends to shareholders.
Drawdowns
NVCT vs. MRNA - Drawdown Comparison
The maximum NVCT drawdown since its inception was -77.89%, smaller than the maximum MRNA drawdown of -93.70%. Use the drawdown chart below to compare losses from any high point for NVCT and MRNA. For additional features, visit the drawdowns tool.
Volatility
NVCT vs. MRNA - Volatility Comparison
The current volatility for Nuvectis Pharma Inc (NVCT) is 20.77%, while Moderna, Inc. (MRNA) has a volatility of 23.69%. This indicates that NVCT experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVCT vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between Nuvectis Pharma Inc and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities